TradeTrade
Jump to any asset 844 assets, updated daily

Bath & Body Works Inc. (BBWI)

Bath & Body Works Inc. NYSE

$18.88 0.8800 (4.89%)
Latest Price
AI Analyst Consensus
Hold
55 / 100
Bath & Body Works Inc. (BBWI) is currently trading at $18.88, below its 200-day simple moving average of $19.83 but above its 50-day SMA of $18.15. The company has demonstrated significant insider buying, with over $1 million in purchases against no reported sales, signaling moderate insider confidence. Recent earnings reports have shown substantial EPS beats, with the latest quarter exceeding estimates by 158.33%. However, the company is experiencing revenue declines, with current quarter and next quarter revenue growth estimates at -3.00% and -2.00% respectively, and negative long-term growth projections. The company's balance sheet presents a risk, as shareholder equity is negative, indicating liabilities exceed assets. This is a critical concern despite the company's positive profit margin of 10.83% and operating margin of 9.58%. The stock's price-to-sales ratio of 0.49 is below the sector median of 1.9, suggesting potential undervaluation, but this is tempered by the negative equity and declining revenue trends. The dividend yield stands at 4.24%.

BBWI at a glance

Bath & Body Works Inc. (BBWI): Hold, 55/100 on CleaRank's AI score.

  • Trend Mixed: the price is above its 50-day but below its 200-day moving average ($18.15 and $19.83).
  • Insiders Insiders bought $1.0M and made no open-market sales over the last 18 months.
  • Valuation P/E of 4.6 against 20.8 for the Consumer Cyclical sector: a discount to peers (-78%).

As of October 14, 2026, Bath & Body Works Inc. (BBWI) trades at $18.88. Wall Street's consensus target is $22.00 across 19 analysts. The 14-day RSI (daily closes) is 61, showing bullish momentum without being overbought, and the price is above its 50-day simple moving average of $18.15.

Figures as of October 14, 2026.

Only on CleaRank

Figures we compute ourselves from BBWI's own price, earnings and insider-filing history. Tap one to see it in context.

BBWI Price Analysis

Market Metrics

Open
$18.06
Day Range
$18.02 to $18.91
Prev Close
$18.00
Volume
611.0K
52-Week Range
$14.28 to $27.40
Market Cap
$3.63B

Peer Benchmarking

Valuation vs Sector (Consumer Cyclical)

Performance vs XRT

Sector Position Analysis
Trading at a notable discount to sector peers (-78%), which may indicate undervaluation or specific company headwinds.

BBWI Financial Performance

Revenue vs. Earnings

Annual

Quarterly

Earnings Reality Check

In the last 2 quarters, BBWI beat the analyst estimate 2 times; the stock fell in the first session after 1 of those beats.
BBWI earnings surprises and the stock's reaction
Report EPS estimate EPS actual Surprise First session 5 sessions
Aug 26, 2026 $0.24 $0.62 +158.33% -1.32% -1.96%
May 27, 2026 $0.29 $0.32 +10.34% +4.68% -7.35%

The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.

As of October 14, 2026, BBWI has beaten the analyst EPS estimate in 2 of its last 2 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 26, 2026, came in 158.33% above the estimate and the stock moved -1.32% in the first session.

BBWI Analysis

Company's Health 2/5
12-Month Analyst Target +16.53% above price
Median of 19 analysts (12-month)
$22.00
AI Analyst Consensus Score Hold
Bath & Body Works Inc. is trading above its 50-day simple moving average of $18.15 and its 20-day exponential moving average of $17.51, indicating some short-term positive momentum. However, the stock remains below its 200-day SMA of $19.83, suggesting a longer-term bearish trend. The 14-day RSI is at 60.99, classified as bullish momentum, and the CCI is at 139.33, indicating strong upward pressure. The current price action suggests a potential short-term bounce is in effect, supported by the bullish RSI and CCI readings. However, the failure to reclaim the 200-day SMA remains a key resistance level. Investors should monitor for sustained trading above $19.83 to confirm a shift in the longer-term trend. The stochastic oscillator is at 99.05, indicating the stock is in overbought territory, which could signal an impending pullback.
Key Catalysts
Bullish Strong EPS Beats Continue

Recent earnings reports have shown significant outperformance against analyst estimates, indicating operational efficiency and potential for profitability improvements.

Source: Company Earnings Reports
Bullish Moderate Insider Buying Activity

Over $1 million in insider purchases with no reported sales suggest a degree of confidence from management in the company's future prospects.

Source: Insider Transaction Filings
Bearish Declining Revenue Trends

Consistent revenue declines and negative forward estimates pose a significant risk to future growth and profitability.

Source: Analyst Estimates
Bearish Negative Shareholder Equity

Liabilities exceeding assets creates a weak balance sheet, posing a risk to financial stability and dividend sustainability.

Source: Company Financial Statements
Market Outlook
The company's ability to consistently beat EPS estimates is a positive, and insider buying provides some support. However, the persistent revenue declines and negative long-term growth projections present significant headwinds that are likely to cap substantial upside. Potential catalysts for upside include a successful turnaround in sales strategy or a significant improvement in consumer spending within the specialty retail sector. Conversely, downside risks are substantial, primarily stemming from the weak balance sheet and the potential for further revenue deterioration. Failure to address the negative shareholder equity could lead to increased scrutiny and limit the company's financial flexibility, potentially impacting its ability to maintain its dividend or invest in growth initiatives.

Key Statistics

Market Cap 3.63B
P/E Ratio 4.61
EPS (TTM) 3.78
Dividend Yield 4.24%
52 Week High 27.40
52 Week Low 14.28

As of October 14, 2026, BBWI trades at $18.88, with a market value of $3.63B, a P/E ratio of 4.61 and a dividend yield of 4.24%.

Bath & Body Works Inc. exhibits a low price-to-sales ratio of 0.49, significantly below the sector median of 1.9, suggesting the stock may be undervalued on a sales basis. The company's P/E ratio of 4.61 is also well below the sector average of 20.8. Despite these valuation metrics, the company's fundamental health is concerning due to negative shareholder equity, indicating that its liabilities exceed its assets. This balance sheet weakness is a significant risk, even with a positive net profit margin of 10.83% and operating margin of 9.58%. Revenue growth has been negative at -2.3%, and forward estimates indicate continued declines in the near term, with current and next quarter revenue growth projected at -3.00% and -2.00% respectively. While the company has a positive return on equity of -50.74%, this figure is distorted by the negative equity. The company pays a dividend yield of 4.24%, but the sustainability of this payout could be impacted by the negative equity and revenue trends.

Earnings & Growth Analysis

Bath & Body Works Inc. has delivered strong earnings beats in its recent reports, significantly exceeding analyst expectations. The latest results reported on August 26, 2026, showed an EPS of $0.62 against an estimate of $0.24, a surprise of 158.33%, although the stock saw a slight price decline of -1.32%. Prior to that, on May 27, 2026, EPS was $0.32 versus an estimate of $0.29, a 10.34% beat, accompanied by a positive price reaction of 4.68%. Despite these beats, forward EPS estimates for the current and next year show a declining trend.

Key Risks

The primary risk for Bath & Body Works Inc. is its precarious balance sheet, characterized by negative shareholder equity, which signals that liabilities outweigh assets. This fundamental weakness is compounded by declining revenue trends and negative long-term growth estimates, suggesting potential challenges in future profitability and cash flow generation. Also, while insider buying is a positive signal, the stock's inability to consistently trade above its 200-day moving average indicates persistent overhead resistance and a lack of strong upward momentum.

Technical Indicators i

RSI (14-day) 60.99
MACD (12, 26) -0.00352
SMA (50-day) 18.15
SMA (200-day) 19.83
Technical Rating Neutral
RSI
Bullish
SMA Cross
Bearish
Price vs SMA
Bullish
MACD
Neutral
Moving averages show a lagging Death Cross (50-day: $18.15, 200-day: $19.83), price sits above the 50-day SMA but below the 200-day SMA - a mixed posture.

As of October 14, 2026, with BBWI at $18.88, its 14-day RSI is 61.0 (showing bullish momentum without being overbought), its 50-day simple moving average is $18.15 and its 200-day is $19.83.

Calculated by CleaRank on daily closes as of October 14, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.40
Weak correlation
Nasdaq 100 (QQQ) +0.35
Weak correlation
Bitcoin (BTC) +0.20
Weak correlation
Gold (XAU) -0.05
Weak correlation

As of October 14, 2026, BBWI's 1-year correlation of daily returns is +0.40 with S&P 500 (SPY), +0.35 with Nasdaq 100 (QQQ), +0.20 with Bitcoin (BTC) and -0.05 with gold (XAU).

Check Custom Correlation

How does any other asset move with BBWI? One year of daily closes, Pearson correlation.

Try

BBWI Wall Street View

12-month price targets

Low $17.00 Median $22.00 (+16.5%) High $54.00

Ratings

Buy 5 Hold 13 Sell 1 3 months ago: 4 of 18 buy

Recent rating actions

Recent analyst rating actions on BBWI
Date Firm Action Rating
Sep 16, 2026 Argus Research Reiterates Hold
Sep 9, 2026 BMO Capital Initiates Market Perform
Aug 27, 2026 Baird Maintains Neutral
Aug 27, 2026 Barclays Maintains Equal-Weight
Aug 27, 2026 UBS Maintains Neutral
Aug 27, 2026 Wells Fargo Maintains Overweight

As of October 14, 2026, 19 Wall Street analysts cover BBWI: 5 rate it a buy or strong buy, 13 a hold and 1 a sell or strong sell. Their 12-month price targets range from $17.00 to $54.00, with a median of $22.00, 16.5% above the price of $18.88.

Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.

BBWI Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Entry Strategies pick an entry style

Conservative
$18.69
Slight discount to current
Wait for small dip
Aggressive
$18.88
At current price
Enter now if confident

Risk Management

STOP LOSS
$17.31
MAX LOSS
-7.4%
Volatility-Adjusted Stop Loss
Calculated based on RSI (61.0) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$19.25
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$19.63
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$20.19
+8% (Conservative)
+6.9% (Aggressive)

BBWI moves about 3.4% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.

Growth of $10,000

A $10,000 investment in BBWI in October 2016 would be worth about $3,041 today, compared with about $36,506 for the same investment in the S&P 500 benchmark. This is price change only; dividends paid along the way would add to it.

Compare with Another Ticker

BBWI Drawdowns & Recovery

Worst fall, last 10 years
-86.7%
October 2016 to March 2020
Recovery
16 months
back at the old peak by July 2021
From the 10-year high
-75.1%
highest close, December 2021
1-year holds that gained
28%
of every 1-year window

As of October 14, 2026, BBWI's worst peak-to-trough fall over the last 10 years was -86.7% (October 2016 to March 2020); it regained that peak by July 2021, 16 months after the low, and 28% of 1-year holding periods ended with a gain.

From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BBWI today could grow to about $7,036 by 2036 in the base case, with a 90th-percentile outcome near $53,381 and a 10th-percentile outcome around $927. The simulation models price only; at today's 4.24% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.

BBWI Stock Price Prediction: 2030

CleaRank's simulation projects a price near $16.40 for BBWI by 2030 in the base case, from $18.88 today (0.9x over 4 years). The 10th-percentile path ends near $4.55. These are outcomes of a Monte Carlo simulation run on BBWI's historical return distribution, not price targets, and they assume no dividends are reinvested.

BBWI simulated price paths by year
Year 10th percentile Base case 90th percentile
2027 $9.60 $18.23 $34.60
2028 $7.11 $17.60 $43.56
2029 $5.60 $16.99 $51.55
2030 $4.55 $16.40 $59.09
2031 $3.78 $15.84 $66.37

Method: a lognormal simulation of BBWI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.

People Also Watch

BBWI Insider Trading Analysis

Source: TwelveData, from SEC Form 4 filings
▲ Bought
$1.0M
6 Transactions
▼ Sold
None
No open-market sells
● Insiders
15
Active Traders
$ Avg Transaction
$167.8K
Moderate size

As of October 14, 2026, BBWI insiders reported no open-market sales and 6 open-market purchases worth $1.0M over the last 18 months; grants and option exercises are not counted.

Recent insider transactions in BBWI
Date Insider Type Shares Value
Aug 10, 2026
ABER ANN
Officer
Grant 12.9K -
Jun 12, 2026
JAVITCH TOM
Chief Financial Officer
Grant 10.3K -
Jun 11, 2026
BOGLIOLO ALESSANDRO
Director
Grant 8.0K -
Jun 11, 2026
BRADY LUCY
Director
Grant 8.0K -
Jun 11, 2026
HONDAL FRANCIS A
Director
Grant 8.0K -
Jun 11, 2026
LEE DANIELLE M
Director
Grant 8.0K -
Jun 11, 2026
NASH SARAH E
Director
Grant 13.3K -
Jun 11, 2026
RAJLIN JUAN
Director
Grant 8.0K -
Jun 11, 2026
STEINOUR STEPHEN D
Director
Grant 8.0K -
Jun 11, 2026
SYMANCYK JAMES KEVIN
Director
Grant 8.0K -

Frequently Asked Questions

How has Bath & Body Works performed in recent earnings reports?
Bath & Body Works Inc. has recently delivered strong earnings beats, exceeding analyst EPS estimates by 158.33% in the latest report (August 26, 2026) and by 10.34% in the prior quarter (May 27, 2026). However, forward EPS estimates show a declining trend.
What is the dividend outlook for Bath & Body Works?
Bath & Body Works Inc. currently offers a dividend yield of 4.24%. While the company has a history of paying dividends, the sustainability of these payouts could be impacted by its negative shareholder equity and declining revenue trends.
How does Bath & Body Works' valuation compare to its sector?
Bath & Body Works Inc. appears undervalued compared to its sector peers, with a price-to-sales ratio of 0.49 versus the sector median of 1.9, and a P/E ratio of 4.61 compared to the sector average of 20.8. However, this valuation is overshadowed by significant balance sheet risks and declining revenue.
Are insiders buying or selling Bath & Body Works stock?
Insiders at Bath & Body Works Inc. are net buyers, with over $1 million in total purchases and no reported sales across recent filings. This 'moderate buy signal' suggests a degree of confidence from management regarding the company's prospects.
What is the current technical outlook for Bath & Body Works stock?
Technically, Bath & Body Works Inc. shows mixed signals. It is trading above its 50-day and 20-day moving averages, supported by bullish 14-day RSI and CCI readings, but remains below its 200-day moving average, indicating a longer-term bearish trend. The stock is also in overbought territory according to the stochastic oscillator.
What is the analyst price target for BBWI?
As of October 14, 2026, the 19 Wall Street analysts covering BBWI have 12-month targets from $17.00 to $54.00, with a median of $22.00, 16.5% above the current price of $18.88. 5 rate it a buy or strong buy, 13 a hold and 1 a sell or strong sell. Three months ago 4 of 18 rated it a buy.
What is BBWI's biggest drop in the last 10 years?
Bath & Body Works Inc. (BBWI)'s worst peak-to-trough fall over the last 10 years was -86.7%, from October 2016 to March 2020. It regained that peak by July 2021, 16 months after the low. Over the same period, 28% of 1-year holding periods ended with a gain.
What are BBWI's best and worst months?
Over the last 10 years, December has been BBWI's strongest month on average (+7.67%, rising in 5 of 10 years) and March its weakest (-9.95%, rising in 2 of 10 years). Seasonal averages describe the past and do not predict a given year.
How closely does BBWI move with the stock market?
Over the past year BBWI's daily returns were weakly correlated with the S&P 500 (SPY) (+0.40). Nasdaq 100 (QQQ): +0.35; Bitcoin (BTC): +0.20; Gold (XAU): -0.05. A figure near +1 means the two usually move together; near 0 means little relationship.
What would $10,000 invested in BBWI be worth today?
$10,000 put into BBWI in October 2016 would be worth about $3,041 today, against about $36,506 for the same amount in the S&P 500.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The stock analysis, trade plans, and AI-generated signals presented for BBWI are for educational and informational purposes only and do not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All trade setups and performance metrics shown are hypothetical, hindsight-based, and simulated. They do not represent actual trades made by CleaRank or its affiliates. Stock prices can be volatile and are subject to market, economic, and company-specific risks. Market data is provided "as-is" and may be delayed by 15 minutes or more. We do not guarantee the accuracy, completeness, or timeliness of any data. You should never invest money you cannot afford to lose. Past performance does not guarantee future results. Consult a qualified financial advisor before making any investment decisions. Analysis generated on October 15, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.